跳转至内容
Merck
CN

SML3420

KY-226

≥97% (HPLC)

别名:

4-((Biphenyl-4-ylmethylthio)methyl)-N-(hexylsulfonyl)benzamide, 4-(Biphenyl-4-ylmethylsulfanylmethyl)-N-(hexane-1-sulfonyl)benzoylamide, 4-[[([1,1′-Biphenyl]-4-ylmethyl)thio]methyl]-N-(hexylsulfonyl)benzamide

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C27H31NO3S2
化学文摘社编号:
分子量:
481.67
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥97% (HPLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥97% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(NS(=O)(CCCCCC)=O)C1=CC=C(CSCC2=CC=C(C3=CC=CC=C3)C=C2)C=C1

InChI

1S/C27H31NO3S2/c1-2-3-4-8-19-33(30,31)28-27(29)26-17-13-23(14-18-26)21-32-20-22-11-15-25(16-12-22)24-9-6-5-7-10-24/h5-7,9-18H,2-4,8,19-21H2,1H3,(H,28,29)

InChI key

MKXMABKUVSOEJF-UHFFFAOYSA-N

Biochem/physiol Actions

KY-226 is an orally bioavailable, potent and selective allosteric inhibitor of protein tyrosine phosphatase 1B (PTP1B) that does not function as a PPARg agonist. KY-226 exhibits anti-diabetic, anti-obesity effects by enhancement of insulin and leptin signaling in mice. It appears that KY-226 exerts neuroprotective effects through restoration of phosphorylation of Akt and FoxO1. Thus, it protects BBB integrity by restoration of tight junction (TJ) proteins in mice.
Orally bioavailable, potent and selective allosteric inhibitor of protein tyrosine phosphatase 1B (PTP1B)


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库